Gastroenterology Practice Questions

Q: A 25-year-old man with a history of Crohn's disease presents with worsening diarrhea and abdominal pain. Which therapeutic strategy would be most appropriate for reducing the progression of his disease?

Anti-TNF monoclonal antibody therapy. A 25-year-old man with a history of Crohn's disease presents with worsening diarrhea and abdominal pain. Which therapeutic strategy would be most appropriate for reducing the progression of his disease? ***Anti-TNF monoclonal antibody therapy*** - **Anti-TNF (tumor necrosis factor) agents** such as infliximab or adalimumab are effective in inducing and maintaining remission in moderate to severe Crohn's disease, thereby reducing disease progression. [1] - They target the **inflammatory cytokine TNF-α**, which plays a central role in the pathogenesis of inflammatory bowel disease (IBD). *Long-term antibiotics* - While antibiotics may be used for specific complications like **perianal disease** or **bacterial overgrowth** in Crohn's, they are not a primary strategy for long-term reduction of disease progression in general. - **Chronic antibiotic use** can lead to side effects such as *Clostridioides difficile* infection and **antibiotic resistance**. *Corticosteroid therapy for 6 months* - **Corticosteroids** are effective for inducing remission in acute flares of Crohn's disease due to their potent anti-inflammatory effects. [1] - However, they are not suitable for **long-term maintenance therapy** due to significant side effects (e.g., bone loss, adrenal suppression, increased infection risk) and do not alter the natural course of the disease. [1] *High-fiber diet and exercise* - A **high-fiber diet** is generally not recommended during active flares of Crohn's disease as it can worsen symptoms like abdominal pain and diarrhea. - While **exercise** is beneficial for overall health, neither dietary changes nor exercise alone are sufficient to reduce the progression of moderate to severe Crohn's disease.

Q: A 30-year-old patient with a history of Crohn's disease presents with acute abdominal pain. A CT scan reveals bowel wall thickening and fat stranding. What is the most likely diagnosis?

Active Crohn's disease. ***Active Crohn's disease*** - The patient's history of **Crohn's disease**, combined with **acute abdominal pain**, and CT findings of **bowel wall thickening** and **fat stranding**, are highly suggestive of an active flare-up [1]. - **Fat stranding** results from inflammation spreading into adjacent mesenteric fat, a common finding in active inflammatory bowel disease. *Intestinal obstruction* - While **bowel wall thickening** can be present in obstruction, the primary CT finding would be **dilated bowel loops** proximal to a transition point, often with air-fluid levels [1]. - Although Crohn's can cause strictures leading to obstruction, the description points more directly to active inflammation. *Diverticulitis* - **Diverticulitis** typically occurs in older individuals and is characterized by inflammation of colonic diverticula, presenting with **left lower quadrant pain** and localized inflammation or abscess. - While it can cause **bowel wall thickening** and **fat stranding**, the patient's history of **Crohn's disease** makes an active flare-up far more likely [1]. *Colonic carcinoma* - **Colonic carcinoma** can cause **bowel wall thickening**, but it often presents as a focal **mass** or **asymmetric thickening** with associated lymphadenopathy, and a more insidious onset of symptoms [1]. - Although patients with Crohn's have an increased risk of colorectal cancer, the acute presentation and diffuse inflammatory signs (fat stranding) point away from primary carcinoma as the most likely immediate cause.

Q: What is the gold standard diagnostic test for a suspected peptic ulcer?

Upper gastrointestinal endoscopy. ***Upper gastrointestinal endoscopy*** - This is the **gold standard** because it allows for direct visualization of the esophagus, stomach, and duodenum, enabling accurate identification and **biopsy** of ulcers [1]. - Endoscopy can also be therapeutic, allowing for interventions like **hemostasis** if bleeding is present [1]. *Barium swallow* - A barium swallow is a **radiologic study** that can identify ulcers as filling defects or craters, but it is less sensitive and specific than endoscopy. - It does not allow for **biopsy** to rule out malignancy or confirm *Helicobacter pylori* infection. *Abdominal ultrasound* - An abdominal ultrasound is primarily used to evaluate **solid organs** like the liver, gallbladder, and kidneys [2]. - It has very limited utility in visualizing the gastric or duodenal mucosa and therefore cannot reliably detect **peptic ulcers**. *CT scan of the abdomen* - A CT scan can detect complications of peptic ulcers such as **perforation** or **obstruction**, but it is not the primary diagnostic tool for identifying the ulcer itself. - It does not offer the same **mucosal detail** or biopsy capability as endoscopy.

Q: A patient presents with a distended abdomen and jaundice. Blood tests reveal elevated ammonia levels. What is the most likely cause of the hyperammonemia?

Liver failure. ***Liver failure*** - **Liver failure** impairs the liver's ability to convert ammonia to urea, leading to its accumulation in the blood [1]. - The symptoms of a **distended abdomen** (due to ascites) and **jaundice** (due to impaired bilirubin metabolism) are classic signs of advanced liver disease [2]. *Kidney failure* - **Kidney failure** primarily affects the excretion of waste products like urea and creatinine, but it is not a direct cause of **hyperammonemia**. - While severe kidney failure can cause some ammonia accumulation, it is typically secondary to impaired renal ammoniagenesis or metabolic acidosis, not the primary mechanism behind the symptoms described. *Pancreatitis* - **Pancreatitis** involves inflammation of the pancreas and typically presents with severe abdominal pain, nausea, and vomiting. - It does not directly cause **jaundice** or **hyperammonemia**, although it can be a complication of underlying conditions that might also affect the liver or bile ducts. *Heart failure* - **Heart failure** can lead to symptoms like edema and shortness of breath, but it does not directly cause **jaundice** or **hyperammonemia**. - While severe right-sided heart failure can cause **congestive hepatopathy** and mild liver dysfunction, it is rarely the primary cause of such pronounced jaundice and hyperammonemia as described.

Q: A 12-year-old boy presents with jaundice, dark urine, and pale stools. He is diagnosed with autoimmune hepatitis. Which antibody is most likely to be positive?

Anti-Smooth Muscle Antibody (ASMA). ***Anti-Smooth Muscle Antibody (ASMA)*** - **Type 1 autoimmune hepatitis** often presents in children and young adults, and is characterized by a high prevalence of **anti-smooth muscle antibodies (ASMA)** and/or **anti-nuclear antibodies (ANA)** [1]. - The presence of **jaundice**, **dark urine**, and **pale stools** in a 12-year-old boy is consistent with acute hepatitis. *Anti-Mitochondrial Antibody* - This antibody is the serological hallmark of **primary biliary cholangitis (PBC)**, an autoimmune disease primarily affecting the small bile ducts, more common in middle-aged women [2]. - It is not typically associated with classic childhood autoimmune hepatitis and would not explain the presented symptoms. *Anti-Liver/Kidney Microsomal Antibody* - This antibody (specifically **anti-LKM1**) is primarily associated with **Type 2 autoimmune hepatitis**, which often affects younger children (preschool age) and can have a more severe clinical course. - While possible, ASMA (and ANA) are most commonly found in Type 1, which has a broader age range including 12-year-olds. *Anti-Nuclear Antibody* - **Anti-nuclear antibody (ANA)** can be positive in Type 1 autoimmune hepatitis, similar to ASMA [1]. - However, ASMA is often more specific for autoimmune hepatitis particularly in patients presenting with these features, while ANA can be positive in many other autoimmune conditions [3].

Q: A 45-year-old male with chronic hepatitis B is being evaluated for antiviral therapy. His HBV DNA levels are elevated, and a liver biopsy shows moderate inflammation and fibrosis. What is the most appropriate antiviral regimen for this patient?

Tenofovir. ***Tenofovir*** - **Tenofovir** is a highly potent **nucleotide analog reverse transcriptase inhibitor** - **First-line therapy for chronic hepatitis B** due to its high barrier to resistance and potent viral suppression. *Interferon therapy* - **Interferon therapy** is an alternative, but it has significant **side effects** and is often **less preferred** for long-term treatment compared to nucleos(t)ide analogs [1]. - It involves weekly injections and can cause **flu-like symptoms**, psychiatric disturbances, and cytopenias [1]. *Lamivudine* - **Lamivudine** is a **nucleoside analog** that has a **low barrier to resistance**, meaning the virus can easily develop mutations that make the drug ineffective over time. - It is **not recommended** as a first-line agent for chronic hepatitis B due to the high risk of resistance. *Adefovir* - **Adefovir** is another **nucleotide analog** that has a **higher risk of nephrotoxicity** (kidney damage) compared to tenofovir. - It is **not a first-line treatment** option due to its less favorable safety profile and lower potency than tenofovir.

Q: A patient with a long history of alcohol use presents with abdominal pain and weight loss. A CT scan shows pancreatic calcifications. Which condition is consistent with these findings?

Chronic pancreatitis. ***Chronic pancreatitis*** - Long-term **alcohol use** can lead to pancreatic damage, causing **calcifications** in the pancreas, as seen on CT [1]. - Symptoms like **abdominal pain and weight loss** are classical signs associated with chronic pancreatic inflammation [1]. *Pancreatic pseudocyst* - Typically arises as a **complication of acute pancreatitis**, characterized by collections of fluid rather than calcifications. - Doesn't usually cause weight loss directly and is often asymptomatic unless gland dysfunction occurs. *Pancreatic adenocarcinoma* - While it may present with weight loss, it typically does not result in **pancreatic calcifications**; rather, it presents with masses on imaging. - Symptoms are usually more insidious, including **jaundice** and new-onset diabetes, not simply abdominal pain. *Acute pancreatitis* - Often associated with severe abdominal pain, but would not show calcifications prominently on imaging. - It typically presents with **edema and fluid collections**, not the chronic fibrosis and calcifications seen in chronic pancreatitis.

Q: A 30-year-old woman presents with abdominal pain, hepatomegaly, and Kayser-Fleischer rings. What disorder is consistent with these findings?

Wilson disease. ***Wilson disease*** - Characterized by **copper accumulation** in tissues [1], which leads to **hepatomegaly** and **Kayser-Fleischer rings** in the cornea. - Symptoms often include **abdominal pain** due to liver involvement and potential neurological effects [1]. *Hemochromatosis* - Involves **iron overload** rather than copper [2], typically leading to **diabetes**, skin pigmentation, and arthropathy. - Kayser-Fleischer rings are not present; they are specific to Wilson disease. *Non-alcoholic fatty liver disease* - Primarily related to **insulin resistance** and does not cause Kayser-Fleischer rings. - Symptoms typically include **elevated liver enzymes** rather than specific neurological or ocular manifestations. *Alpha-1 antitrypsin deficiency* - Associated with **lung disease** and sometimes liver disease but lacks Kayser-Fleischer rings and has different clinical features. - Often presents with **pulmonary symptoms** such as **emphysema** along with liver issues.

Q: A 45-year-old woman with a history of irritable bowel syndrome presents with chronic abdominal pain, bloating, and diarrhea. Which of the following is most likely to improve her symptoms?

Low-FODMAP diet. ***Low-FODMAP diet*** - This diet restricts **fermentable oligosaccharides, disaccharides, monosaccharides, and polyols**, which are poorly absorbed carbohydrates that can ferment in the gut, causing gas, bloating, and pain common in **irritable bowel syndrome (IBS)** [1]. - Clinical trials have shown that a **low-FODMAP diet** can significantly reduce symptoms like **abdominal pain**, **bloating**, and **diarrhea** in a substantial number of IBS patients [1]. *High-fiber diet* - While fiber is generally healthy, a **high-fiber diet** can exacerbate symptoms such as **bloating** and **gas** in some IBS patients, particularly those with IBS-D (diarrhea-predominant IBS), due to increased colonic fermentation. - The type of fiber matters; **soluble fiber** may be better tolerated than **insoluble fiber** for IBS symptoms, but increasing overall fiber can still worsen symptoms for many. *Lactose-free diet* - A **lactose-free diet** is beneficial only if the patient has **lactose intolerance**, which can mimic some IBS symptoms [2]. However, not all IBS patients are lactose intolerant, and adopting this diet won't address other dietary triggers. - While lactose intolerance can coexist with IBS, it's a specific food intolerance, and eliminating lactose alone is unlikely to alleviate the broad spectrum of IBS symptoms if other **FODMAPs** are still being consumed [2]. *Probiotics* - **Probiotics** can be helpful for some IBS patients by modulating gut microbiota and reducing inflammation, but their efficacy varies widely among individuals and specific strains. - While recommended as a potential adjunct therapy, **probiotics** are generally not considered the *most likely* single intervention to comprehensively improve all primary symptoms of IBS-D like a **low-FODMAP diet** [1].

Q: A 25-year-old male patient presents with jaundice, dark urine, and elevated liver enzymes. He tests positive for HBsAg and HBeAg. What is the most appropriate treatment?

Tenofovir. ***Tenofovir*** - This patient presents with **acute hepatitis B** (jaundice, dark urine, elevated liver enzymes, HBsAg, HBeAg), indicating active viral replication [1]. **Tenofovir** is a highly effective **nucleotide analog reverse transcriptase inhibitor** used to treat chronic HBV infection, and can be used in severe acute cases or those at risk of chronicity [1]. - It works by inhibiting the **HBV reverse transcriptase**, thereby reducing viral load and preventing liver damage. *Acyclovir* - **Acyclovir** is an antiviral medication specifically used to treat **herpes simplex virus (HSV)** and **varicella-zoster virus (VZV)** infections [3]. - It has no activity against the **hepatitis B virus (HBV)**, making it ineffective for this patient's condition [3]. *Ribavirin* - **Ribavirin** is an antiviral drug primarily used in combination with other agents, such as interferon, for the treatment of **hepatitis C virus (HCV)** infection. - It is **not effective** against the hepatitis B virus and is not indicated for the management of acute or chronic HBV. *Interferon-alpha* - **Interferon-alpha** is an immunomodulatory agent that can be used to treat both chronic **hepatitis B** and **hepatitis C** infections [2]. - However, for acute severe hepatitis B, **nucleoside/nucleotide analogs like tenofovir** are generally preferred due to better tolerability and higher antiviral efficacy in rapidly reducing viral replication [1].

Question 1

A 25-year-old man with a history of Crohn's disease presents with worsening diarrhea and abdominal pain. Which therapeutic strategy would be most appropriate for reducing the progression of his disease?

Accepted Answer

Anti-TNF monoclonal antibody therapy

Answer

Long-term antibiotics

Answer

Corticosteroid therapy for 6 months

Answer

High-fiber diet and exercise

Question 2

A 30-year-old patient with a history of Crohn's disease presents with acute abdominal pain. A CT scan reveals bowel wall thickening and fat stranding. What is the most likely diagnosis?

Accepted Answer

Active Crohn's disease

Answer

Intestinal obstruction

Answer

Diverticulitis

Answer

Colonic carcinoma

Question 3

What is the gold standard diagnostic test for a suspected peptic ulcer?

Accepted Answer

Upper gastrointestinal endoscopy

Answer

Barium swallow

Answer

Abdominal ultrasound

Answer

CT scan of the abdomen

Question 4

A patient presents with a distended abdomen and jaundice. Blood tests reveal elevated ammonia levels. What is the most likely cause of the hyperammonemia?

Accepted Answer

Liver failure

Answer

Kidney failure

Answer

Pancreatitis

Answer

Heart failure

Question 5

A 12-year-old boy presents with jaundice, dark urine, and pale stools. He is diagnosed with autoimmune hepatitis. Which antibody is most likely to be positive?

Accepted Answer

Anti-Smooth Muscle Antibody (ASMA)

Answer

Anti-Mitochondrial Antibody

Answer

Anti-Liver/Kidney Microsomal Antibody

Answer

Anti-Nuclear Antibody

Question 6

A 45-year-old male with chronic hepatitis B is being evaluated for antiviral therapy. His HBV DNA levels are elevated, and a liver biopsy shows moderate inflammation and fibrosis. What is the most appropriate antiviral regimen for this patient?

Accepted Answer

Tenofovir

Answer

Interferon therapy

Answer

Lamivudine

Answer

Adefovir

Question 7

A patient with a long history of alcohol use presents with abdominal pain and weight loss. A CT scan shows pancreatic calcifications. Which condition is consistent with these findings?

Accepted Answer

Chronic pancreatitis

Answer

Acute pancreatitis

Answer

Pancreatic pseudocyst

Answer

Pancreatic adenocarcinoma

Question 8

A 30-year-old woman presents with abdominal pain, hepatomegaly, and Kayser-Fleischer rings. What disorder is consistent with these findings?

Accepted Answer

Wilson disease

Answer

Hemochromatosis

Answer

Alpha-1 antitrypsin deficiency

Answer

Non-alcoholic fatty liver disease

Question 9

A 45-year-old woman with a history of irritable bowel syndrome presents with chronic abdominal pain, bloating, and diarrhea. Which of the following is most likely to improve her symptoms?

Accepted Answer

Low-FODMAP diet

Answer

High-fiber diet

Answer

Lactose-free diet

Answer

Probiotics

Question 10

A 25-year-old male patient presents with jaundice, dark urine, and elevated liver enzymes. He tests positive for HBsAg and HBeAg. What is the most appropriate treatment?

Accepted Answer

Tenofovir

Answer

Acyclovir

Answer

Ribavirin

Answer

Interferon-alpha

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?